natgillin/translations-raw huggingface dataset:
These can be mild or moderate (likely to occur in approximately 4 out of 100 people who take Vectibix), or severe (likely to occur in less than 1 out of 100 people who take Vectibix).
Te reakcije so lahko blage ali zmerne (predvidoma se pojavijo pri približno 4 od 100 bolnikov, ki uporabljajo zdravilo Vectibix), ali hude (predvidoma se pojavijo pri manj kot 1 od 100 bolnikov, ki uporabljajo zdravilo Vectibix).
These can be recognised by: itchy rash of the hands and feet,
Prepoznati jih je mogoče po: srbečem izpuščaju na rokah in stopalih, oteklosti oči in obraza,
These can include:
Mednje lahko spadajo:
These can include:
Vključujejo lahko:
These can occasionally be painful, warm or reddened.
Ta je lahko boleča, topla ali rdeča.
These can occasionally be painful, warm or reddened.
Ta je lahko občasno boleča, topla ali rdeča.
These capsules come in special packaging to prevent children removing them
Kapsule so zaprte v posebnem pakiranju, ki preprečuje, da bi jih iz njega vzeli otroci.
These capsules contain glycerol, which can cause adverse effects in high doses.
Te kapsule vsebujejo glicerol, ki lahko pri velikih odmerkih povzroči neželene učinke.
These capsules should be swallowed whole with water.
Kapsule mora otrok pogoltniti cele z vodo.
These capsules should be swallowed whole with water.
Kapsule morate pogoltniti cele z vodo.
These cardiovascular events can be life-threatening and may lead to death.
Našteti srčno žilni dogodki so lahko življenjsko ogrožajoči in se lahko končajo s smrtjo.
These carrier medicines have been specially developed for use with Lutetium (177Lu) chloride and may be substances that have been designed to recognise a particular type of cell in the body.
Ta nosilna zdravila so bila posebej razvita za uporabo z lutecijevim (177Lu) kloridom in so lahko snovi, zasnovane za prepoznavanje določene vrste celic v telesu.
These cartridges are for use with a 3 mL pen only.
Ti vložki so namenjeni izključno uporabi s 3-ml peresnikom.
These cartridges are for use with a 3 ml pen only.
Ti vložki so namenjeni samo uporabi s 3 ml injekcijskim peresnikom.
These cartridges should not be used with any other reusable pen as the dosing accuracy has only been established with the listed pens.
Ti vložki se ne smejo uporabljati z injekcijskimi peresniki za ponovno uporabo, ker je natančnost odmerjanja dokazana samo za omenjene injekcijske peresnike.
These cases are excluded in the HPV type assignment analysis (see under Table).
Ti primeri so bili izključeni iz analize razporeditve tipa HPV (glejte pod preglednico).
These cases reinforce the importance of strict adherence to the monthly schedule for monitoring of liver function for the duration of treatment with STAYVEER (see section 4.4).
Ti primeri še poudarjajo pomen doslednosti upoštevanja mesečnega režima nadziranja delovanja jeter v času trajanja zdravljenja z zdravilom STAYVEER (glejte poglavje 4.4).
These cases reinforce the importance of strict adherence to the monthly schedule for monitoring of liver function for the duration of treatment with Tracleer (see section 4.4).
Ti primeri še poudarjajo pomen doslednosti upoštevanja mesečnega režima nadziranja delovanja jeter v času trajanja zdravljenja z zdravilom Tracleer (glejte poglavje 4.4).
These cases were identified within the first 5 months of dabrafenib as monotherapy.
Ugotovljeni so bili v prvih 5 mesecih zdravljenja z dabrafenibom v monoterapiji.
These cells are then mixed outside the patient’s body with a ‘fusion protein’, which is taken up by the cells.
Tem celicam nato zunaj bolnikovega telesa primešajo „fuzijsko beljakovino“, ki jo privzamejo celice.
These cells are ‘characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins’.
To so karakterizirane viabilne avtologne hrustančne celice, ekspandirane ex vivo, ki izražajo specifične markerske proteine.
These cells collect in the bone marrow and divide out of control.
Te celice se kopičijo v kostnem mozgu in se nekontrolirano razmnožujejo.
These changes are considered acceptable.
Te spremembe se štejejo za sprejemljive.
These changes are consistent with the gastric emptying delay of dulaglutide and within the pharmacokinetic variability of metformin and thus are not clinically relevant.
Te spremembe so skladne z zakasnitvijo praznjenja želodca, povzročeno z dulaglutidom in so zajete v farmakokinetični variabilnosti metformina, zato niso klinično pomembne.
These changes are not considered
Ti spremembi se ne smatrata
These changes are not considered
Ti spremembi se ne smatrata za
These changes are reversible after treatment cessation.
Po koncu zdravljenja so bile te spremembe reverzibilne.
These changes are suggested following conclusions by the PRAC upon review of zoledronic acid PSUR.
Te spremembe so bile po oceni PSUR s strani odbora PRAC že predlagane za zolendronsko kislino.
These changes may suggest a ‘left shift’ in the maturity of neutrophils in haematological investigations, which may be mistakenly interpreted as a sign of infection in immunosuppressed patients such as those that receive CellCept.
Te spremembe lahko pri preiskavah krvi predstavljajo ‘premik v levo’ pri zorenju nevtrofilcev, kar se lahko pri imunosupresiranih bolnikih, kot so ti, ki prejemajo zdravilo CellCept, napačno razlaga kot znak okužbe.
These changes may suggest a ‘left shift’ in the maturity of neutrophils in haematological investigations, which may be mistakenly interpreted as a sign of infection in immunosuppressed patients such as those that receive Mycophenolate mofetil Teva.
Te spremembe lahko pri preiskavah krvi predstavljajo ‘premik v levo’ pri zorenju nevtrofilcev, kar se lahko pri imunosupresiranih bolnikih, kot so ti, ki prejemajo zdravilo Mofetilmikofenolat Teva, napačno tolmači kot znak okužbe.
These changes may suggest a ‘left shift’ in the maturity of neutrophils in haematological investigations, which may be mistakenly interpreted as a sign of infection in immunosuppressed patients such as those that receive mycophenolate mofetil.
Te spremembe lahko pri preiskavah krvi predstavljajo ‘premik v levo’ pri zorenju nevtrofilcev, kar se lahko pri imunosupresiranih bolnikih, kot so ti, ki prejemajo mofetilmikofenolat, napačno razlaga kot znak okužbe.
These changes may suggest a ‘left shift’ in the maturity of neutrophils in haematological investigations, which may be mistakenly interpreted as a sign of infection in immunosuppressed patients such as those that receive Myfenax.
Te spremembe lahko pri preiskavah krvi predstavljajo ‘premik v levo’ pri zorenju nevtrofilcev, kar se lahko pri imunosupresiranih bolnikih, kot so ti, ki prejemajo zdravilo Myfenax, napačno tolmači kot znak okužbe
These changes may suggest a ‘left shift’ in the maturity of neutrophils in haematological investigations, which may be mistakenly interpreted as a sign of infection in immunosuppressed patients such as those that receive Myfenax.
Te spremembe lahko pri preiskavah krvi predstavljajo ‘premik v levo’ pri zorenju nevtrofilcev, kar se lahko pri imunosupresiranih bolnikih, kot so ti, ki prejemajo zdravilo Myfenax, napačno tolmači kot znak okužbe.
These changes sometimes give the cartridge a frosted appearance.
Te spremembe včasih dajo videz, kot bi bil vložek zamrznjen.
These changes were believed to be consistent with the toxic effects of other intrathecal agents such as unencapsulated cytarabine.
Za te spremembe domnevajo, da so sovpadale s toksičnimi učinki drugih intratekalnih učinkovin, kot je neinkapsulirani citarabin.
These changes were not considered to be clinically meaningful as the maximum tolerated dose (4-6 mg/m2) of mifamurtide is 2-3 times the recommended dose (2 mg/m2).
Te spremembe niso ocenili za klinično pomembne, saj je največji prenosljivi odmerek mifamurtida (4-6 mg/m2) za 2- do 3-krat večji od priporočenega odmerka (2 mg/m2).
These changes were observed at the first assessment (week 4) after the initial Simponi administration and were generally maintained through week 24.
Izboljšanje bistvenih meril aktivnosti bolezni so opazili že ob prvi oceni (v 4. tednu) po prvi uporabi zdravila Simponi in se je ohranjalo v času do 24. tedna.
These channels are used for the transport of ions (charged atoms and molecules) in and out of cells.
Ti kanalčki se uporabljajo za prenos ionov (nabitih atomov in molekul) v celico in ven iz nje.
These channels are used for the transport of ions (charged atoms and molecules) in and out of the secretion-producing cells.
Kanalčki se uporabljajo za prehod ionov (nabitih atomov in molekul) v celice, ki tvorijo izločke, in iz njih.
These characteristics had no clinically meaningful effect on the pharmacokinetics of sitagliptin based on a composite analysis of Phase I pharmacokinetic data and on a population pharmacokinetic analysis of Phase I and Phase II data.
Na osnovi sestavljene analize farmakokinetičnih podatkov iz I. faze in analize populacijske farmakokinetike na osnovi podatkov iz I. in II. faze te značilnosti nimajo kliničnega pomena za farmakokinetiko sitagliptina.
These characteristics had no clinically meaningful effect on the pharmacokinetics of sitagliptin based on a composite analysis of Phase I pharmacokinetic data and on a population pharmacokinetic analysis of Phase I and Phase II data.
Na podlagi sestavljene analize farmakokinetičnih podatkov iz I. faze in analize populacijske farmakokinetike na podlagi podatkov iz I. in II. faze te značilnosti nimajo kliničnega pomena za farmakokinetiko sitagliptina.
These chelating agents help elimination of copper radiotoxicity by an exchange between the calcium ion and the copper due to their capacity of forming water soluble complexes with the chelating ligands (DTPA, EDTA).
Ti kelatorji zavirajo radiotoksičnost bakra z izmenjavo med kalcijevimi ioni in bakrom na podlagi zmožnosti bakra, da z ligandi za kelatiranje (DTPA, EDTA) tvori v vodi topne komplekse.
These clinical signs disappear within 7 days without any particular treatment.
Ta klinična znamenja izginejo brez kakršne koli posebne terapije v sedmih dneh.
These clinically significant adverse reactions were reported in clinical trials but the grade 3-5 reactions did not meet the threshold of at least a 2% difference compared to the control arm.
O teh klinično pomembnih neželenih učinkih so poročali v kliničnih preskušanjih, a neželeni učinki stopenj 3 do 5 niso dosegli meje – najmanj 2-% razlike v primerjavi s kontrolno skupino.
These clots, which include deep vein thrombosis (DVT), can be dangerous if they move to another part of the body such as the lungs.
Ti strdki, ki vključujejo tudi globoko vensko trombozo, so lahko nevarni, če se premaknejo v drug del telesa, npr. v pljuča.
These CNS effects may include loss of righting reflex, decreased activity, eyelid closure, lacrimation, dry eye and nystagmus.
Učinki na OŽS lahko vključujejo izgubo izravnalnega refleksa, zmanjšano dejavnost, zaprtje veke, solzenje, suho oko in nistagmus.
These collagenases, referred to as AUX-I and AUX-II, are representative of the two major collagenase classes (Class I and Class II) produced by Clostridium histolyticum.
Ti dve kolagenazi, ki jih imenujemo AUX-I in AUX-II, sta predstavnici dveh glavnih razredov kolagenaz (razred I in razred II), ki jih izdeluje Clostridium histolyticum.
These compared monthly injections of Eylea 2 mg with a sham injection using a syringe without a needle.
V teh so primerjali mesečno injiciranje zdravila Eylea v odmerku 2 mg z navidezno injekcijo, pri kateri se uporabi brizga brez igle.
These compared Revolade with placebo for allowing the starting and maintenance of antiviral treatment in patients with hepatitis C whose platelet count was initially too low to allow starting such treatment (less than 75,000 per microlitre).
V okviru teh študij so zdravilo Revolade primerjali s placebom, da bi ugotovili, ali omogoča začetno in vzdrževalno protivirusno terapijo pri bolnikih s hepatitisom C, katerih število trombocitov je bilo ob začetku zdravljenja prenizko, da bi lahko pri njih uvedli tovrstno terapijo (nižje od 75 000 na mikroliter).
These compatible filters are luer adaptor-type of Polyacrylic housing with integrated filter element of a Polyamide screen of 5 – 20 micrometer mesh size.
Filtri, ki so združljivi z luer adapterjem, so iz poliakrilnega ohišja z vgrajenim filtrom iz poliamidne mreže z velikostjo luknjic 5 – 20 mikrometrov.
These complications are caused by the break- down products of dying cancer cells and may include the following: changes to blood chemistry; high potassium, phosphorus, uric acid, and low calcium consequently leading to changes in kidney function, heart beat, seizures, and sometimes death.
Te zaplete povzročajo razgradni produkti odmirajočih rakavih celic in lahko vključujejo naslednje: spremenjene rezultate krvnih preiskav; visoko raven kalija, fosforja, sečne kisline in nizko raven kalcija, kar posledično povzroči spremembe v delovanju ledvic, utripu srca, konvulzije in včasih smrt,
These complications include fractures (breaks in the bone), spinal compression (when the spinal cord is compressed by the bone), or complications requiring radiotherapy (treatment with radiation) or surgery.
Zapleti vključujejo zlome kosti, spinalno kompresijo (ko kost stisne hrbtenjačo) ali z okostjem povezane dogodke, pri katerih je potrebna radioterapija (zdravljenje z obsevanjem) ali kirurški poseg.
These compounds act at the same receptor system as memantine, and therefore adverse reactions (mainly central nervous system (CNS)-related may be more frequent or more pronounced (see also section 4.5).
Te snovi delujejo na isti receptorski sistem kot memantin, zato so lahko neželeni učinki (zlasti s strani osrednjega živčnega sistema (OŽS)) pogostejši in bolj izraženi (glejte tudi poglavje 4.5).
These compounds act by blocking types of enzymes known as protein kinases.
Te spojine zavirajo vrste encimov, ki jim pravimo protein-kinaze.
These compounds act by blocking types of enzymes known as protein kinases.
Te spojine zavirajo vrste encimov, znanih kot protein-kinaze.
These compounds work by blocking enzymes known as protein kinases, which can be found in some receptors on the surface of cancer cells including HER2.
Te spojine delujejo tako, da zavirajo vrste encimov, znane kot proteinske kinaze, ki se nahajajo v nekaterih receptorjih na površini rakavih celic, med drugim tudi pri beljakovini HER2.
These comprised 3 (0.3%) patients with mild corneal erosion, 2 (0.2%) patients with eyelid oedema and 1 (0.1%) patient each with abnormal sensation in eye, corneal oedema, or eye pruritus.
3 (0,3 %) bolniki z blago erozijo roženice, 2 (0,2 %) z edemom veke in po 1 (0,1 %) bolnik z nenormalnim občutkom v očesu, edemom roženice ali očesnim pruritusom.
These comprised 7 cases (1.5%) of uncomplicated macular oedema and 12 cases (2.6%) of cystoid macular oedema.
Ti so vključevali 7 primerov (1,5%) nekompliciranega makularnega edema in 12 primerov (2,6%) cistoidnega makularnega edema.
These concentrations can be expected to produce surgical anaesthesia in 3 to 14 minutes and may be set initially, or may be achieved gradually over the course of 1 to 2 minutes.
Lahko pričakujemo, da bodo te koncentracije povzročile kirurško anestezijo v 3 do 14 minutah in jih lahko nastavimo že v začetku ali jih dosežemo postopoma v 1 do 2 minutah.
These concentrations can be expected to produce surgical anaesthesia within 3 to 14 minutes and may be set initially, or may be achieved gradually over the course of 1 to 2 minutes.
Lahko pričakujemo, da bodo te koncentracije povzročile kirurško anestezijo v 3 do 14 minutah, in jih lahko nastavimo že v začetku ali jih dosežemo postopoma v 1 do 2 minutah.
These conditions and other symptoms and signs known to be associated with GH treatment in general should be monitored during INCRELEX treatment.
Splošno pravilo je, da je treba med zdravljenjem z zdravilom INCRELEX ta stanja in druge simptome in znake, za katere je znano, da so povezani z zdravljenjem z GH, spremljati.
These conditions include patients with a personal or family history of QT prolongation, electrolyte abnormalities, congestive heart failure, bradyarrhythmia, conduction disturbances and in patients taking anti-arrhythmic medicinal products or other medicinal products that lead to QT prolongation or electrolyte abnormalities.
Ta stanja zajemajo bolnike z osebno ali družinsko anamnezo podaljšanja intervala QT, motenj elektrolitov, kongestivnega srčnega popuščanja, bradiaritmije ali motenj prevajanja ter bolnike, ki jemljejo zdravila proti aritmijam ali druga zdravila, ki povzročajo podaljšanje intervala QT ali motnje elektrolitov.
These could be signs of an allergic reaction.
To so lahko znaki alergijske reakcije;
These could be signs of an allergic reaction. if you suffer from confusion, worsening of seizures or decreased consciousness which can be signs of low blood salt levels.
To so lahko znaki alergijske reakcije. če se pojavijo zmedenost, poslabšanje epileptičnih napadov ali zmanjšana zavest, kar so lahko znaki nizke ravni soli v krvi.
These could be signs of an allergic reaction. you suffer from confusion, worsening of seizures or decreased consciousness which can be signs of low blood salt levels
To so lahko znaki alergijske reakcije. se pojavijo zmedenost, poslabšanje epileptičnih napadov ali zmanjšana zavest, kar so lahko znaki nizkih ravni soli v krvi.
These could be signs of bone damage in the ear.
To so lahko znaki poškodbe ušesnih kosti,
These could be signs of bone damage in the ear.
To so lahko znaki poškodbe ušesnih kosti;
These could be signs of bone damage in the ear. itching, swelling of your face, lips, tongue and throat with difficulty breathing.
To so lahko znaki poškodbe ušesnih kosti; srbenje, otekanje obraza, ustnic, jezika in žrela s težkim dihanjem.
These could be signs of bone damage in the ear. itching, swelling of your face, lips, tongue and throat, with difficulty breathing.
To so lahko znaki poškodbe kosti v ušesu; srbenje, otekanje obraza, ustnic, jezika in žrela s težkim dihanjem.
These could be signs of bone damage in the ear. itching, swelling of your face, lips, tongue and throat, with difficulty breathing.
To so lahko znaki poškodbe ušesnih kosti; srbenje, otekanje obraza, ustnic, jezika in žrela s težkim dihanjem.
These could be signs of bone damage in the ear. itching, swelling of your face, lips, tongue and throat, with difficulty breathing.
To so lahko znaki poškodbe ušesnih kosti;  srbenje, otekanje obraza, ustnic, jezika in žrela s težkim dihanjem.
These could be symptoms of a condition reported with other medicines similar to Lonquex called “capillary leak syndrome”, which causes blood to leak from the small blood vessels into your body and needs urgent medical attention.
To so lahko simptomi stanja, o katerem so poročali pri uporabi drugih zdravil, ki so podobna zdravilu Lonquex, imenovanega "sindrom kapilarne prepustnosti", ki povzroči puščanje krvi iz drobnih krvnih žilic v telesu in zahteva nujno zdravniško pomoč.
These could be symptoms of an increase of pressure in your eye and can happen within hours to weeks of taking Rasilez HCT.
To sta lahko simptoma povečanega tlaka v očesu in se lahko pojavita v nekaj urah do nekaj tednih jemanja zdravila Rasilez HCT.
These could be symptoms of an inflammation of the lungs (interstitial lung disease) and can be life- threatening. if you develop acute or worsening redness and pain in the eye, increased eye watering, blurred vision and/or sensitivity to light.
To so lahko simptomi vnetja pljuč (intersticijske pljučne bolezni), ki je lahko življenjsko nevarno. če se pojavijo akutna ali slabšajoča se pordelost ali bolečina v očesu, povečano solzenje oči, meglen vid ali občutljivost za svetlobo.
These could be symptoms of an uncommon condition (may affect up to 1 in 100 people) called Capillary Leak Syndrome which causes the blood to leak from the small blood vessels into your body and needs urgent medical attention. if you experience kidney injury (glomerulonephritis).
Lahko gre za simptome občasnega stanja (pojavi se lahko pri največ 1 od 100 bolnikov), ki se imenuje sindrom povečane prepustnosti kapilar in povzroči uhajanje krvi iz drobnih krvnih žil v vaše telo ter zahteva nujno medicinsko pomoč. če se vam pojavi poškodba ledvic (glomerulonefritis).
These could be symptoms of anaemia.
To so lahko znaki slabokrvnosti.
These could be symptoms of severe allergic reactions to insulins and may become life threatening.
To so lahko znaki hude alergijske reakcije na insuline in lahko postanejo smrtno nevarni.
These could be symptoms of severe allergic reactions to insulins and may become life-threatening.
To so lahko znaki hude alergijske reakcije na insuline in lahko postanejo smrtno nevarni.
These could include infections of the nose, sinus or throat (upper respiratory tract infection), or lung, or skin. bruising or increased tendency of bruising.
Lahko gre za okužbo nosu, sinusov ali grla oziroma žrela (okužba zgornjih dihal) ter okužbo pljuč ali kože. podplutbe, ali povečana nagnjenost k nastanku podplutb
These cytokines are involved in inflammation and other processes that are important in psoriasis, psoriatic arthritis and Crohn’s disease.
Ta citokina sta udeležena v vnetnih in drugih procesih, ki so pomembni pri psoriazi, psoriatičnem artritisu in Crohnovi bolezni.
These data also suggest that varicella vaccination may reduce the risk of herpes zoster in vaccinated individuals.
Ti podatki nakazujejo tudi, da cepljenje proti noricam lahko zmanjšuje tveganje za pojav pasavca pri cepljenih posameznikih.
These data are insufficient to support a dosing recommendation in patients with severe hepatic impairment..
Ti podatki pa niso zadostni, da bi upravičili priporočilo za prilagoditev odmerka pri bolnikih s hudo motnjo v delovanju jeter.
These data are preliminary.
Ti podatki so predhodni.
These data are presented in Table 8.
Ti podatki so prikazani v preglednici 8.
These data are supplemented with the use of levetiracetam in corresponding open- label extension studies, as well as post-marketing experience.
Ti podatki so dopolnjeni s podatki iz ustreznih odprtih, razširjenih študij o uporabi levetiracetama ter s postmarketinškimi podatki.
These data do not allowan effective and safe dose recommendation.
Ti podatki ne dopuščajo priporočil o učinkovitem in varnem odmerku.
These data help to clarify the mechanisms by which some of the ECG changes (particularly QT and QRS prolongation) associated with this class of substance can occur.
Ti podatki pomagajo pojasniti mehanizme, s katerimi lahko nastanejo nekatere od elektrokardiografskih sprememb (posebno podaljšanje QT in QRS), povezanih s to skupino substanc.
These data in conjunction with animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal or postnatal development (see section 5.3).
Ti podatki skupaj s študijami na živalih ne kažejo na neposredne ali posredne škodljive vplive na nosečnost, razvoj zarodka/plodu ali postnatalni razvoj (glejte poglavje 5.3).
These data indicate that concentrations of isavuconazole required for inhibition in vitro are very variable between genera/species within the order of Mucorales, and generally higher than concentrations required to inhibit Aspergillus species.
Ti podatki kaţejo na to, da so koncentracije izavukonazola potrebne za inhibicijo in vitro, zelo spremenljive med rodovi/vrstami znotraj reda Mucorales in na splošno višje od koncentracij potrebnih za vrste gliv Aspergillus.
These data indicate that concentrations of isavuconazole required for inhibition in vitro are very variable between genera/species within the order of Mucorales, and generally higher than concentrations required to inhibit Aspergillus species.
Ti podatki kaţejo na to, da so koncentracije izavukonazola, potrebne za inhibicijo in vitro, zelo spremenljive med rodovi/vrstami znotraj reda Mucorales in na splošno višje od koncentracij, potrebnih za vrste gliv Aspergillus.
These data indicate that younger children might require higher bodyweight-adjusted doses than adolescents and adults to achieve similar target concentrations.
Ti podatki kažejo, da utegnejo mlajši otroci za doseganje podobnih tarčnih koncentracij potrebovati večje odmerke, prirejene na telesno maso, kot mladostniki in odrasli.